financetom
Business
financetom
/
Business
/
Germany in deal to cut Huawei's role in 5G wireless network, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Germany in deal to cut Huawei's role in 5G wireless network, sources say
Jul 10, 2024 9:19 AM

BERLIN, July 10 (Reuters) - The German government and

mobile phone carriers have agreed in principle on steps to phase

components by Chinese technology companies out of the nation's

5G wireless network over the next five years, two people

familiar with the matter told Reuters on Wednesday.

Newspaper Sueddeutsche Zeitung as well as broadcasters NDR

and WDR earlier jointly reported the news, saying the agreement

gives network operators Deutsche Telekom, Vodafone ( VOD )

and Telefonica Deutschland more time

to replace critical parts.

Under the preliminary agreement driven by security

considerations, operators will initially rid the country's core

network of 5G data centres of technology made by companies such

as Huawei and ZTE (Shenzhen:000063) in 2026, said the

sources, adding that a final pact has yet to be signed.

In a second phase, the role of Chinese makers' parts for

antennas, transmission lines and towers should be all but

eliminated by 2029, they added.

Asked for comment, Germany's interior ministry told Reuters

that the government's talks with mobile carriers were ongoing.

"The government is acting on the basis of the national

security strategy and China strategy to reduce possible security

risks and dependencies," a spokesperson said.

The Chinese embassy in Germany did not immediately respond

to a request for comment.

Germany is considered a laggard in implementing the European

Union's security measures for 5G networks.

Telecoms operators in the country have previously resisted

Berlin's efforts to drive the expensive phase-out of Huawei,

while Huawei has rejected what it called the "politicisation" of

cyber security in the country.

Reflecting the costs of a transition, the U.S.

communications regulator said in May that nearly 40% of U.S.

telecom companies need additional government funding to remove

equipment made by Chinese telecoms firms from American wireless

networks to address security risks.

(Writing by Ludwig Burger, additional reporting by Sarah Marsh;

Editing by Rachel More and Emelia Sithole-Matarise)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson discontinues dengue drug study
Johnson & Johnson discontinues dengue drug study
Oct 4, 2024
Oct 4 (Reuters) - Johnson & Johnson ( JNJ ) said on Friday it will discontinue its mid-stage field study evaluating the efficacy of its antiviral drug candidate for the prevention of dengue. ...
Tellurian shareholders back proposed $1.2 billion Woodside deal
Tellurian shareholders back proposed $1.2 billion Woodside deal
Oct 4, 2024
(Reuters) - Tellurian shareholders have voted in favor of the U.S. LNG developer's proposed $1.2 billion acquisition by Australian energy producer Woodside Energy Group, the company said on Friday. Shares rose 1.4% to 98 cents in premarket trade. Woodside in July agreed to buy Tellurian, including its U.S. Gulf Coast Driftwood LNG export project. The agreement is expected help solve...
Iris Energy Reports Higher Bitcoin Mining Output in September
Iris Energy Reports Higher Bitcoin Mining Output in September
Oct 4, 2024
09:26 AM EDT, 10/04/2024 (MT Newswires) -- Iris Energy ( IREN ) said Friday it mined 347 bitcoins in September, up from 245 in August. The company said its mining revenue in September was $21.4 million, up from $15 million in August, while its average operating hashrate increased to 16.5 exahash per second from 10.9 EH/s in August. Shares of...
J&J discontinues dengue drug study
J&J discontinues dengue drug study
Oct 4, 2024
(Reuters) -Johnson & Johnson ( JNJ ) said on Friday it will discontinue a mid-stage field study evaluating the efficacy of its antiviral drug candidate for the prevention of dengue. The decision to discontinue the study was part of a reprioritization of the company's communicable diseases research and development portfolio, J&J said. In another mid-stage study, six of 10 participants...
Copyright 2023-2025 - www.financetom.com All Rights Reserved